Gilead and Arcus Biosciences Announce Positive Update on Joint TIGIT Program From Interim Analysis of ARC-7 Study in Non-small Cell Lung Cancer Pharmaceutical Investing
VISIONARY-MS Trial Results Featured in Platform Presentation at PACTRIMS 2022: CNM-Au8® Demonstrated Global Neurological Improvement in Stable MS Patients as Adjunct to Background Disease Modifying Therapies Life Science Investing
The Impact of Inaction - New Publication Reveals Not All of Canada is on Track to Meet Global Hepatitis C Elimination Goal Pharmaceutical Investing
Sirona Biochem Signs International Partnership Agreement with Wanbang Biopharmaceuticals Life Science Investing
AbbVie Announces European Commission Approval of SKYRIZI® for the Treatment of Moderate to Severe Active Crohn's Disease Pharmaceutical Investing
AbbVie Highlights Blood Cancer Data From Its Growing Oncology Pipeline at the 64th ASH Annual Meeting Pharmaceutical Investing
U.S. FDA Accepts for Priority Review the Biologics License Application for Epcoritamab for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma Pharmaceutical Investing
